Apolipoprotein A-I Is a Selective Target for Myeloperoxidase-Catalyzed Oxidation and Functional Impairment in Subjects With Cardiovascular Disease

Journal of Clinical Investigation - United States
doi 10.1172/jci21109
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Oxidation of Apolipoprotein A-I by Myeloperoxidase Impairs the Initial Interactions With ABCA1 Required for Signaling and Cholesterol Export

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2010English

Cardiovascular Disease Risk Associated With Serum Apolipoprotein B Is Modified by Serum Vitamin A

Atherosclerosis
Cardiovascular MedicineCardiology
2017English

Myeloperoxidase: A Target for New Drug Development?

British Journal of Pharmacology
Pharmacology
2007English

A Mini Review About Tip60 Functional Mechanism: A Potential Therapeutic Target in Cardiovascular Disease

Journal of Integrative Cardiology
2018English

Apolipoprotein Profiles in Subjects With and Without Peripheral Artery Disease

Vascular Medicine
MedicineCardiovascular MedicineCardiology
2013English

Glutathione Oxidation Is Associated With Airway Macrophage Functional Impairment in Children With Severe Asthma

Pediatric Research
Child HealthPediatricsPerinatology
2011English

Is High-Density Lipoprotein a Modifiable Treatment Target or Just a Biomarker for Cardiovascular Disease?

JRSM Cardiovascular Disease
2019English

Heart Rate: A Global Target for Cardiovascular Disease and Therapy Along the Cardiovascular Disease Continuum

Journal of Cardiology
Cardiovascular MedicineCardiology
2013English

Lower HDL-C and Apolipoprotein A-I Are Related to Higher Glomerular Filtration Rate in Subjects Without Kidney Disease

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy